Cognitive Training Using VR Contents

Not Applicable

Recruiting

• Conditions: Endocrine, nutritional and metabolic diseases

• Registration Number: KCT0007014
• Lead Sponsor: The Catholic University of Korea

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 8 March 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Overweight to obesity: between 23 and 34.9 kg/m2 on the Body Mass Index
- Adult men and women between the ages of 19 and 75
- Those with a score of 24 or higher based on the Korean Version of Mini Mental Status Examination (MMSE-KC)
- Those who voluntarily consent to the study and are able to visit for the next observation

Exclusion Criteria

- Hearing impairment accompanied by severe visual loss
- Patients with severe movement disorders
- Women who are pregnant
- If a new history of severe wasting diseases such as thyroid disease, liver disease, or kidney disease is diagnosed within 3 months of the test
- Severe infection, metabolic acidosis, acromegaly, Cushing's syndrome
- Patients with psychiatric disorders that can seriously affect the nervous system or take drugs
- In case of intracranial surgery history and magnetic material inserted into the head or eyeball
- When implants such as artificial pacemakers, hearing aids, or drug infusion pumps
- Have a history or symptom of epilepsy or seizure disorder
- A clinically significant disease in renal (glomerulonephritis, renal failure), cardiac (angina pectoris, myocardial infarction, heart failure), respiratory (respiratory failure syndrome), or nervous system (stroke, encephalitis, and meningitis)
- Patients who do not understand or do not agree with the contents of the study
- Patients judged to be inappropriate by other researchers

Study & Design

• Study Type: Interventional Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Changes in CERAD-K after 4 weeks from baseline

Secondary Outcome Measures

Name	Time	Method
Structural/functional (parenchymal volume, gray matter thickness, functional connectivity) changes in brain imaging;Changes in psychological state (anxiety, depression scale);Changes in heart rate variability;Changes in Cognitive function test result in VR device